Search Results

Filter
  • 1-10 of  89,544 results for ""HIV-1""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The cell biology of HIV-1 latency and rebound.

  • Authors : Mbonye U; Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA. .; Karn J

Subjects: HIV-1*/HIV-1*/HIV-1*/physiology ; HIV Infections*; Humans

  • Source: Retrovirology [Retrovirology] 2024 Apr 05; Vol. 21 (1), pp. 6. Date of Electronic Publication: 2024 Apr 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101216893 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-4690

Record details

×
Academic Journal

HIV-1 Myeloid Reservoirs - Contributors to Viral Persistence and Pathogenesis.

  • Authors : Ferreira EA; Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA.; Clements JE

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/pathology ; Simian Acquired Immunodeficiency Syndrome*/Simian Acquired Immunodeficiency Syndrome*/Simian Acquired Immunodeficiency Syndrome*/pathology ; HIV-1*

  • Source: Current HIV/AIDS reports [Curr HIV/AIDS Rep] 2024 Apr; Vol. 21 (2), pp. 62-74. Date of Electronic Publication: 2024 Feb 27.Publisher: Current Science Country of Publication: United States NLM ID: 101235661 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A two-step mechanism for the binding of the HIV-1 MPER epitope by the 10E8 antibody onto biosensor-supported lipid bilayers.

  • Authors : García-Porras M; Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), Bilbao, Spain.; Torralba J

Subjects: Lipid Bilayers* ; HIV-1*/HIV-1*/HIV-1*/genetics ; HIV-1*/HIV-1*/HIV-1*/chemistry

  • Source: FEBS letters [FEBS Lett] 2024 Apr; Vol. 598 (7), pp. 787-800. Date of Electronic Publication: 2024 Feb 09.Publisher: John Wiley & Sons Ltd Country of Publication: England NLM ID: 0155157 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Rational design, synthesis and biological evaluation of novel HIV-1 protease inhibitors containing 2-phenylacetamide derivatives as P2 ligands with potent activity against DRV-Resistant HIV-1 variants.

  • Authors : Meng S; Jiangsu Key Laboratory of New drug and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221006, China; Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.

Subjects: HIV Protease Inhibitors* ; HIV-1*/HIV-1*/HIV-1*/genetics ; Benzeneacetamides*

  • Source: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2024 Mar 15; Vol. 101, pp. 129651. Date of Electronic Publication: 2024 Feb 09.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Changes in Inflammatory Cytokine Levels in Rectal Mucosa Associated With Neisseria gonorrheae and/or Chlamydia trachomatis Infection and Treatment Among Men Who Have Sex With Men in Lima, Peru.

  • Authors : Clark JL; David Geffen School of Medicine, Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, California, USA.; Oldenburg CE

Subjects: Gonorrhea*/Gonorrhea*/Gonorrhea*/diagnosis ; Sexual and Gender Minorities* ; Chlamydia Infections*/Chlamydia Infections*/Chlamydia Infections*/diagnosis

  • Source: The Journal of infectious diseases [J Infect Dis] 2024 Mar 14; Vol. 229 (3), pp. 845-854.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2a.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV-1*/HIV-1*/HIV-1*/genetics ; Panobinostat*/Panobinostat*/Panobinostat*/therapeutic use

  • Source: Cell [Cell] 2024 Feb 29; Vol. 187 (5), pp. 1238-1254.e14. Date of Electronic Publication: 2024 Feb 17.Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

In vivo selection of anti-HIV-1 gene-modified human hematopoietic stem/progenitor cells to enhance engraftment and HIV-1 inhibition.

  • Authors : Guo Q; UCLA AIDS Institute, UCLA, Los Angeles, CA 90024, USA; UCLA School of Nursing, UCLA, Los Angeles, CA 90095, USA.

Subjects: HIV-1*/HIV-1*/HIV-1*/physiology ; Hematopoietic Stem Cell Transplantation*; Humans

  • Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Feb 07; Vol. 32 (2), pp. 384-394. Date of Electronic Publication: 2023 Dec 12.Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Modeling and Analysis of HIV-1 Pol Polyprotein as a Case Study for Predicting Large Polyprotein Structures.

  • Authors : Hao M; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.; Imamichi T

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV-1*/HIV-1*/HIV-1*/genetics ; HIV-1*/HIV-1*/HIV-1*/metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 02; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 02.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Investigation of Immunostimulatory Effects of IFN-γ Cytokine and CD40 Ligand Costimulatory Molecule for Development of HIV-1 Therapeutic Vaccine Candidate.

  • Authors : Heidarnejad F; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, 1316943551, Iran.; Bolhassani A

Subjects: HIV-1*/HIV-1*/HIV-1*/genetics ; Vaccines, DNA*/Vaccines, DNA*/Vaccines, DNA*/pharmacology ; Vaccines, DNA*/Vaccines, DNA*/Vaccines, DNA*/genetics

  • Source: Advanced biology [Adv Biol (Weinh)] 2024 Feb; Vol. 8 (2), pp. e2300402. Date of Electronic Publication: 2023 Oct 15.Publisher: Wiley-VCH GmbH Country of Publication: Germany NLM ID: 101775319 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Validation of digital droplet PCR assays for cell-associated HIV-1 DNA, HIV-1 2-LTR circle, and HIV-1 unspliced RNA for clinical studies in HIV-1 cure research.

  • Authors : Reed J; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA, United States.; Kwak G

Subjects: HIV-1*/HIV-1*/HIV-1*/genetics ; HIV Infections*/HIV Infections*/HIV Infections*/diagnosis ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy

  • Source: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2024 Feb; Vol. 170, pp. 105632. Date of Electronic Publication:Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9815671 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  89,544 results for ""HIV-1""